Skip to main content
Monday, November 16, 2026Nov 16

Chattem readies biggest launch after FDA OKs Allegra over counter

photo Contributed Photo Sanofi-Aventis U.S. and its U.S. Consumer Healthcare Division, Chattem Inc., announced that the U.S. Food and Drug Administration has approved the Allegra® family of allergy medication products for over-the-counter use in adults and children 2 years of age and older.

Prescription allergy drug Allegra has won federal approval for over-the-counter use as Chattanooga-based Chattem puts into place its biggest-ever marketing and distribution plan aiming for a March launch.

While Chattem heavily markets brands such as Icy Hot and Gold Bond, the Allegra rollout will surpass anything it has done in TV, print and digital, said Zan Guerry, Chattem’s chief executive officer.

In an unexpected move, Chattem workers in the city are packaging at least 30 percent of Allegra, he said in a telephone interview Tuesday.

“Speed is a necessity to getting it all done,” he said, adding that Chattem is using parts of all three of its Chattanooga plants. “We’re doing more here than originally anticipated.”

While the packaging lines are fully automated, Guerry said Chattem has brought in temporary workers. He said there’s “an excellent chance” Chattanooga will keep much of the packaging work.